Hypothalamic inflammation and the central nervous system control of energy homeostasis

Molecular and Cellular Endocrinology

Volumn 397, Issue 1-2, 2014, Pages 15-22

  Pimentel, Gustavo D ^a   Ganeshan, Kirthana ^b   Carvalheira, José B C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Cytokines; Hypothalamus; Inflammation; Obesity; Peripheral tissues

Indexed keywords

INSULIN; LEPTIN;

ANIMAL; ANOREXIA; BIOLOGICAL MODEL; CENTRAL NERVOUS SYSTEM; COMPLICATION; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; INFLAMMATION; METABOLISM; OBESITY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANOREXIA; CENTRAL NERVOUS SYSTEM; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; INFLAMMATION; INSULIN; LEPTIN; MODELS, BIOLOGICAL; OBESITY; SIGNAL TRANSDUCTION;

EID: 84914163652     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.06.005     Document Type: Review

References (152)

1. Anand B.K., Brobeck J.R. Hypothalamic control of food intake in rats and cats. Yale J. Biol. Med 1951, 24:123-140.
2. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med 2005, 11:191-198.
3. Arruda A.P., Milanski M., Coope A., Torsoni A.S., Ropelle E., Carvalho D.P., et al. Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion. Endocrinology 2011, 152:1314-1326.
4. Bernard, C., 1854. Leçons de physiologie expérimentale appliqupée à la mpédecine: faites au collège de France. Tome I, Cours du semestre d'hiver, Paris, J.-B. Baillière.
5. Bjorbaek C., Uotani S., da Silva B., Flier J.S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem 1997, 272:32686-32695.
6. Bjorbaek C., Buchholz R.M., Davis S.M., Bates S.H., Pierroz D.D., Gu H., et al. Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem 2001, 276:4747-4755.
7. Bjorbak C., Lavery H.J., Bates S.H., Olson R.K., Davis S.M., Flier J.S., et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem 2000, 275:40649-40657.
8. Bode J.G., Nimmesgern A., Schmitz J., Schaper F., Schmitt M., Frisch W., et al. LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett 1999, 463:365-370.
9. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-2125.
10. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med 2005, 11:183-190.
11. Calegari V.C., Torsoni A.S., Vanzela E.C., Araujo E.P., Morari J., Zoppi C.C., et al. Inflammation of the hypothalamus leads to defective pancreatic islet function. J. Biol. Chem 2011, 286:12870-12880.
12. Cao L., Liu X., Lin E.J., Wang C., Choi E.Y., Riban V., et al. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell 2010, 142:52-64.
13. Caricilli A.M., Picardi P.K., de Abreu L.L., Ueno M., Prada P.O., Ropelle E.R., et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol 2011, 9:e1001212.
14. Carvalheira J.B., Siloto R.M., Ignacchitti I., Brenelli S.L., Carvalho C.R., Leite A., et al. Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS Lett 2001, 500:119-124.
15. Carvalheira J.B., Ribeiro E.B., Araujo E.P., Guimaraes R.B., Telles M.M., Torsoni M., et al. Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia 2003, 46:1629-1640.
16. Carvalheira J.B., Torsoni M.A., Ueno M., Amaral M.E., Araujo E.P., Velloso L.A., et al. Cross-talk between the insulin and leptin signaling systems in rat hypothalamus. Obes. Res 2005, 13:48-57.
17. Carvalheira J.B., Qiu Y., Chawla A. Blood spotlight on leukocytes and obesity. Blood 2013, 122:3263-3267.
18. Carvalho-Filho M.A., Ueno M., Hirabara S.M., Seabra A.B., Carvalheira J.B., de Oliveira M.G., et al. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 2005, 54:959-967.
19. Chakravarthy M.V., Zhu Y., Yin L., Coleman T., Pappan K.L., Marshall C.A., et al. Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation. J. Lipid Res 2009, 50:630-640.
20. Coleman D.L. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973, 9:294-298.
21. Coleman D.L., Hummel K.P. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 1973, 9:287-293.
22. Cota D., Proulx K., Smith K.A., Kozma S.C., Thomas G., Woods S.C., et al. Hypothalamic mTOR signaling regulates food intake. Science 2006, 312:927-930.
23. Dagon Y., Hur E., Zheng B., Wellenstein K., Cantley L.C., Kahn B.B. P70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake. Cell Metab 2012, 16:104-112.
24. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L., Boschero A.C., et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146:4192-4199.
25. DeBoer M.D., Zhu X.X., Levasseur P., Meguid M.M., Suzuki S., Inui A., et al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 2007, 148:3004-3012.
26. Ehlting C., Lai W.S., Schaper F., Brenndorfer E.D., Matthes R.J., Heinrich P.C., et al. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade. J. Immunol 2007, 178:2813-2826.
27. Ehses J.A., Meier D.T., Wueest S., Rytka J., Boller S., Wielinga P.Y., et al. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia 2010, 53:1795-1806.
28. Emanuelli B., Peraldi P., Filloux C., Chavey C., Freidinger K., Hilton D.J., et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J. Biol. Chem 2001, 276:47944-47949.
29. Erin N., Duymus O., Ozturk S., Demir N. Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis. Regul. Pept 2012, 179:101-108.
30. Faubert B., Boily G., Izreig S., Griss T., Samborska B., Dong Z., et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab 2013, 17:113-124.
31. Ferrante A.W. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Int. Med 2007, 262:408-414.
32. Flores M.B., Rocha G.Z., Damas-Souza D.M., Osorio-Costa F., Dias M.M., Ropelle E.R., et al. Obesity-induced increase in tumor necrosis factor-alpha leads to development of colon cancer in mice. Gastroenterology 2012, 143(741-53):e1-e4.
33. Foster M.W., McMahon T.J., Stamler J.S. S-nitrosylation in health and disease. Trends Mol. Med 2003, 9:160-168.
34. Gelin J., Moldawer L.L., Lonnroth C., Sherry B., Chizzonite R., Lundholm K. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 1991, 51:415-421.
35. Ghilardi N., Skoda R.C. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol 1997, 11:393-399.
36. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., Skoda R.C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 1996, 93:6231-6235.
37. Han M.S., Jung D.Y., Morel C., Lakhani S.A., Kim J.K., Flavell R.A., et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 2013, 339:218-222.
38. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
39. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol 2012, 13:251-262.
40. Haslett P.A. Anticytokine approaches to the treatment of anorexia and cachexia. Semin. Oncol 1998, 25:53-57.
41. Hervey G.R. The effects of lesions in the hypothalamus in parabiotic rats. J. Physiol 1959, 145:336-352.
42. Heymsfield S.B., Greenberg A.S., Fujioka K., Dixon R.M., Kushner R., Hunt T., et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999, 282:1568-1575.
43. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., et al. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
44. Holzer R.G., Park E.J., Li N., Tran H., Chen M., Choi C., et al. Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 2011, 147:173-184.
45. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci 1995, 18:83-88.
46. Hossain P., Kawar B., El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Eng. J. Med 2007, 356:213-215.
47. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
48. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
49. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
50. Iyer A., Fairlie D.P., Prins J.B., Hammock B.D., Brown L. Inflammatory lipid mediators in adipocyte function and obesity. Nat. Rev. Endocrinol 2010, 6:71-82.
51. Kellerer M., Koch M., Metzinger E., Mushack J., Capp E., Haring H.U. Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 1997, 40:1358-1362.
52. Kiba T., Tanaka K., Endo O., Inoue S. Role of vagus nerve in increased DNA synthesis after hypothalamic ventromedial lesions in rat liver. Am. J. Physiol 1992, 262. G483-7.
53. Kievit P., Howard J.K., Badman M.K., Balthasar N., Coppari R., Mori H., et al. Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab 2006, 4:123-132.
54. Konner A.C., Bruning J.C. Selective insulin and leptin resistance in metabolic disorders. Cell Metab 2012, 16:144-152.
55. Lage R., Dieguez C., Vidal-Puig A., Lopez M. AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol. Med 2008, 14:539-549.
56. Laviano A., Gleason J.R., Meguid M.M., Yang Z.J., Cangiano C., Rossi Fanelli F. Effects of intra-VMN mianserin and IL-1ra on meal number in anorectic tumor-bearing rats. J. Invest. Med 2000, 48:40-48.
57. Laviano A., Meguid M.M., Rossi-Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 2003, 4:686-694.
58. Lee E.Y., Inoue S., Senoo A., Shimizu H., Suzuki Y., Ishizuka N., et al. Beneficial effects of ventromedial hypothalamus (VMH) lesioning on function and morphology of the liver after hepatectomy in rats. Brain Res 2011, 1421:82-89.
59. Licinio J., Wong M.L. Pathways and mechanisms for cytokine signaling of the central nervous system. J. Clin. Invest 1997, 100:2941-2947.
60. Lira F.S., Yamashita A.S., Rosa J.C., Tavares F.L., Caperuto E., Carnevali L.C., et al. Hypothalamic inflammation is reversed by endurance training in anorectic-cachectic rats. Nutr. Metab (Lond). 2011, 8:60.
61. Liu X., McMurphy T., Xiao R., Slater A., Huang W., Cao L. Hypothalamic gene transfer of BDNF inhibits breast cancer progression and metastasis in middle age obese mice. Mol. Ther 2014.
62. Lopez M., Lage R., Saha A.K., Perez-Tilve D., Vazquez M.J., Varela L., et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 2008, 7:389-399.
63. Lopez M., Varela L., Vazquez M.J., Rodriguez-Cuenca S., Gonzalez C.R., Velagapudi V.R., et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat. Med 2010, 16:1001-1008.
64. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest 2007, 117:175-184.
65. Mantovani G., Maccio A., Lai P., Massa E., Ghiani M., Santona M.C. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin. Oncol 1998, 25:45-52.
66. Marshall H.E., Hess D.T., Stamler J.S. S-nitrosylation: physiological regulation of NF-kappaB. Proc. Natl. Acad. Sci. USA 2004, 101:8841-8842.
67. Martinez de Morentin P.B., Martinez-Sanchez N., Roa J., Ferno J., Nogueiras R., Tena-Sempere M., et al. Hypothalamic mTOR: the rookie energy sensor. Curr. Mol. Med 2014, 14:3-21.
68. Martins L., Fernandez-Mallo D., Novelle M.G., Vazquez M.J., Tena-Sempere M., Nogueiras R., et al. Hypothalamic mTOR signaling mediates the orexigenic action of ghrelin. PLoS ONE 2012, 7:e46923.
69. Matthys P., Billiau A. Cytokines and cachexia. Nutrition 1997, 13:763-770.
70. Mayer C.M., Belsham D.D. Palmitate attenuates insulin signaling and induces endoplasmic reticulum stress and apoptosis in hypothalamic neurons: rescue of resistance and apoptosis through adenosine 5' monophosphate-activated protein kinase activation. Endocrinology 2010, 151:576-585.
71. McNay D.E., Briancon N., Kokoeva M.V., Maratos-Flier E., Flier J.S. Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J. Clin. Invest 2012, 122:142-152.
72. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
73. Meng Q., Cai D. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)/NF-kappaB pathway. J. Biol. Chem 2011, 286:32324-32332.
74. Mercer J.G., Hoggard N., Williams L.M., Lawrence C.B., Hannah L.T., Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996, 387:113-116.
75. Milanski M., Degasperi G., Coope A., Morari J., Denis R., Cintra D.E., et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci 2009, 29:359-370.
76. Milanski M., Arruda A.P., Coope A., Ignacio-Souza L.M., Nunez C.E., Roman E.A., et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 2012, 61:1455-1462.
77. Miller N.E. Experiments on motivation. Studies combining psychological, physiological, and pharmacological techniques. Science 1957, 126:1271-1278.
78. Moldawer L.L., Rogy M.A., Lowry S.F. The role of cytokines in cancer cachexia. JPEN J. Parenter Enteral Nutr 1992, 16:43S-49S.
79. Moraes J.C., Coope A., Morari J., Cintra D.E., Roman E.A., Pauli J.R., et al. High-fat diet induces apoptosis of hypothalamic neurons. PLoS ONE 2009, 4:e5045.
80. Myers M.G., Cowley M.A., Munzberg H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol 2008, 70:537-556.
81. Myers M.G., Leibel R.L., Seeley R.J., Schwartz M.W. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol. Metab 2010, 21:643-651.
82. Nakamura T., Furuhashi M., Li P., Cao H., Tuncman G., Sonenberg N., et al. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 2010, 140:338-348.
83. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
84. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem 2007, 282:35279-35292.
85. Nguyen K.D., Qiu Y., Cui X., Goh Y.P., Mwangi J., David T., et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011, 480:104-108.
86. Niswender K.D., Baskin D.G., Schwartz M.W. Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends Endocrinol. Metab 2004, 15:362-369.
87. Noguchi Y., Yoshikawa T., Matsumoto A., Svaninger G., Gelin J. Are cytokines possible mediators of cancer cachexia?. Surg. Today 1996, 26:467-475.
88. Odegaard J.I., Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013, 339:172-177.
89. Odegaard J.I., Chawla A. The immune system as a sensor of the metabolic state. Immunity 2013, 38:644-654.
90. Okin D., Medzhitov R. Evolution of inflammatory diseases. Curr. Biol 2012, 22:R733-R740.
91. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol 2010, 72:219-246.
92. O'Neill L.A., Hardie D.G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013, 493:346-355.
93. Osório-Costa F., Carvalheira J.C. TNF-α in obesity-associated colon cancer. Trans. Gastrointest. Cancer 2013, 2(4):179-193. 2, 15.
94. Pal A., Barber T.M., Van de Bunt M., Rudge S.A., Zhang Q., Lachlan K.L., et al. PTEN mutations as a cause of constitutive insulin sensitivity and obesity. N Eng. J. Med 2012, 367:1002-1011.
95. Park E.J., Lee J.H., Yu G.Y., He G., Ali S.R., Holzer R.G., et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010, 140:197-208.
96. Phillips M.S., Liu Q., Hammond H.A., Dugan V., Hey P.J., Caskey C.J., et al. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet 1996, 13:18-19.
97. Pimentel G.D., Lira F.S., Rosa J.C., Oliveira J.L., Losinskas-Hachul A.C., Souza G.I., et al. Intake of trans fatty acids during gestation and lactation leads to hypothalamic inflammation via TLR4/NFkappaBp65 signaling in adult offspring. J. Nutr. Biochem 2012, 23:265-271.
98. Posey K.A., Clegg D.J., Printz R.L., Byun J., Morton G.J., Vivekanandan-Giri A., et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab 2009, 296. E1003-12.
99. Prada, P.O., Zecchin, H.G., Gasparetti, A.L., Torsoni, M.A., Ueno, M., Hirata, A.E., etal., 2005. 146, 1576-1587.
100. Purkayastha S., Zhang G., Cai D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB. Nat. Med 2011, 17:883-887.
101. Radley-Crabb H.G., Marini J.C., Sosa H.A., Castillo L.I., Grounds M.D., Fiorotto M.L. Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophy. PLoS ONE 2014, 9:e89277.
102. Ranson S.W., Fisher C., Ingram W.R. Adiposity and diabetes mellitus in a monkey with hypothalamic lesions. Endocrinology 1938, 23:175-181.
103. Reynaert N.L., Ckless K., Korn S.H., Vos N., Guala A.S., Wouters E.F., et al. Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc. Natl. Acad. Sci. USA 2004, 101:8945-8950.
104. Ropelle E.R., Pauli J.R., Zecchin K.G., Ueno M., de Souza C.T., Morari J., et al. A central role for neuronal adenosine 5'-monophosphate-activated protein kinase in cancer-induced anorexia. Endocrinology 2007, 148:5220-5229.
105. Ropelle E.R., Pauli J.R., Fernandes M.F., Rocco S.A., Marin R.M., Morari J., et al. A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in high-protein diet-induced weight loss. Diabetes 2008, 57:594-605.
106. Ropelle E.R., Flores M.B., Cintra D.E., Rocha G.Z., Pauli J.R., Morari J., et al. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol 2010, 8:e1000465.
107. Ropelle E.R., Pauli J.R., Cintra D.E., da Silva A.S., De Souza C.T., Guadagnini D., et al. Targeted disruption of inducible nitric oxide synthase protects against aging, S-nitrosation, and insulin resistance in muscle of male mice. Diabetes 2013, 62:466-470.
108. Rother E., Kuschewski R., Alcazar M.A., Oberthuer A., Bae-Gartz I., Vohlen C., et al. Hypothalamic JNK1 and IKKbeta activation and impaired early postnatal glucose metabolism after maternal perinatal high-fat feeding. Endocrinology 2012, 153:770-781.
109. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1995, 18:130-136.
110. Saberi M., Woods N.B., de Luca C., Schenk S., Lu J.C., Bandyopadhyay G., et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 2009, 10:419-429.
111. Saper C.B., Romanovsky A.A., Scammell T.E. Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat. Neurosci 2012, 15:1088-1095.
112. Scarlett J.M., Jobst E.E., Enriori P.J., Bowe D.D., Batra A.K., Grant W.F., et al. Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology 2007, 148:4217-4225.
113. Schneider J.G., Finck B.N., Ren J., Standley K.N., Takagi M., Maclean K.H., et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 2006, 4:377-389.
114. Schwartz M.W., Seeley R.J., Campfield L.A., Burn P., Baskin D.G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest 1996, 98:1101-1106.
115. Scrivo R., Vasile M., Bartosiewicz I., Valesini G. Inflammation as "common soil" of the multifactorial diseases. Autoimmun. Rev 2011, 10:369-374.
116. Sell H., Habich C., Eckel J. Adaptive immunity in obesity and insulin resistance. Nat. Rev. Endocrinol 2012, 8:709-716.
117. Senn J.J., Klover P.J., Nowak I.A., Zimmers T.A., Koniaris L.G., Furlanetto R.W., et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem 2003, 278:13740-13746.
118. Sherry B.A., Gelin J., Fong Y., Marano M., Wei H., Cerami A., et al. Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. Faseb J. 1989, 3:1956-1962.
119. Shi H., Tzameli I., Bjorbaek C., Flier J.S. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J. Biol. Chem 2004, 279:34733-34740.
120. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest 2006, 116:3015-3025.
121. Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007, 6:386-397.
122. Speakman J.R. A nonadaptive scenario explaining the genetic predisposition to obesity: the "predation release" hypothesis. Cell Metab 2007, 6:5-12.
123. Stamler J.S., Hess D.T. Nascent nitrosylases. Nat. Cell Biol 2010, 12:1024-1026.
124. Sternberg E.M. Neural-immune interactions in health and disease. J. Clin. Invest 1997, 100:2641-2647.
125. Tabas I., Glass C.K. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 2013, 339:166-172.
126. Takeda K., Akira S. TLR signaling pathways. Semin. Immunol 2004, 16:3-9.
127. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271.
128. Teitelbaum P., Stellar E. Recovery from the failure to eat produced by hypothalamic lesions. Science 1954, 120:894-895.
129. Thaler J.P., Schwartz M.W. Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 2010, 151:4109-4115.
130. Thaler J.P., Yi C.X., Schur E.A., Guyenet S.J., Hwang B.H., Dietrich M.O., et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest 2012, 122:153-162.
131. Tisdale M.J. Biology of cachexia. J. Nat. Cancer Inst 1997, 89:1763-1773.
132. Tobias D.K., Pan A., Jackson C.L., O'Reilly E.J., Ding E.L., Willett W.C., et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Eng. J. Med 2014, 370:233-244.
133. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
134. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest 2007, 117:289-296.
135. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B., Prada P.O., Hirabara S.M., Schenka A.A., et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56:1986-1998.
136. Ueki K., Kondo T., Kahn C.R. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell Biol 2004, 24:5434-5446.
137. Vaisse C., Halaas J.L., Horvath C.M., Darnell J.E., Stoffel M., Friedman J.M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet 1996, 14:95-97.
138. Varela L., Martinez-Sanchez N., Gallego R., Vazquez M.J., Roa J., Gandara M., et al. Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism. J. Pathol 2012, 227:209-222.
139. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
140. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest 2003, 112:1796-1808.
141. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest 2006, 116:115-124.
142. Woods A.J., Stock M.J. Leptin activation in hypothalamus. Nature 1996, 381:745.
143. Woods S.C., Lotter E.C., McKay L.D., Porte D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979, 282:503-505.
144. Wu J.J., Roth R.J., Anderson E.J., Hong E.G., Lee M.K., Choi C.S., et al. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 2006, 4:61-73.
145. Xu A.W., Kaelin C.B., Takeda K., Akira S., Schwartz M.W., Barsh G.S. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J. Clin. Invest 2005, 115:951-958.
146. Yi C.X., Al-Massadi O., Donelan E., Lehti M., Weber J., Ress C., et al. Exercise protects against high-fat diet-induced hypothalamic inflammation. Physiol. Behav 2012, 106:485-490.
147. Yoshimoto S., Loo T.M., Atarashi K., Kanda H., Sato S., Oyadomari S., et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013, 499:97-101.
148. Zabolotny J.M., Bence-Hanulec K.K., Stricker-Krongrad A., Haj F., Wang Y., Minokoshi Y., et al. PTP1B regulates leptin signal transduction in vivo. Dev. Cell 2002, 2:489-495.
149. Zabolotny J.M., Kim Y.B., Welsh L.A., Kershaw E.E., Neel B.G., Kahn B.B. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J. Biol. Chem 2008, 283:14230-14241.
150. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
151. Zhang X., Zhang G., Zhang H., Karin M., Bai H., Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008, 135:61-73.
152. Zheng W., McLerran D.F., Rolland B., Zhang X., Inoue M., Matsuo K., et al. Association between body-mass index and risk of death in more than 1 million Asians. N Eng. J. Med 2011, 364:719-729.